In Alzheimer’s disease, overexpression of BCL6 attenuates Aβ-induced neuronal damage and Tau protein hyperphosphorylation, thereby ameliorating neurodegenerative pathology [80]. The gene discussed is MAPT; the disease is Alzheimer disease.